Explore groundbreaking studies on DNA methylation, histone modifications, and non-coding RNA mechanisms
Exploring the phase I/II study of pembrolizumab for progressive diffuse large B-cell lymphoma after CAR-T therapy failure, including mechanisms, clinical trial data, and future directions.